~~~
Fair warning, this chapter includes a good amount of biology and technical terms. I tried my best to explain most of it, and many parts are simplified, but some might find it confusing.
Nevertheless, I hope you enjoy it.
Kat
~~~
"So, we can change the DNA of new cells but can't replace the old cells easily. So what if, instead of waiting for the natural death of the cells, we replace them ourselves?" I explained.
Nea looked confused, "How would that work? We don't have a way to replace cells."
"You sure?" I said, lifting my left hand.
I could hear the realization in her voice, "Ohhh, the MedHands. Yes, that could work, but we would need to adapt some parts of each system for them to work together."
"Yes, but this is a technical problem, not a biological one. And I can help with technical problems." I said, walking to the door, "I'll meet you in the Admin room."
"If I'm not mistaken, the MedHands use nanobots and stem cells to replace damaged cells, right?" I said after I sat down in the admin room.
"Yes, that's about right. Since the MedHands was in the final test, I have the complete technical specifications. Do you want an explanation of how it works?" Nea asked.
"Yes, please. I might not understand everything, but the more I know about it, the better we can develop a solution."
Nea nodded, and the display showed a flow diagram. She also opened multiple technical files on the desk so I could look at them.
"The TL;DR; is that the device extracts some cells, then it uses a process called iPSC to convert these cells back to a pluripotent stem cell state. This state is the second most potent state a stem cell can have. The only state more potent is totipotent, which is unnecessary for this context. The additional capability totipotent stem cells have is that they can create extraembryonic tissues. Pluripotent stem cells can differentiate, meaning they can convert themselves, into almost every other cell type except extraembryonic."
Nea showed an image comparing the different stem cell types. The topmost one was totipotent, followed by pluripotent, multipotent, oligopotent, and unipotent. The chart was fascinating, showing what each type of stem cell could differentiate into. I studied the chart before I continued to listen to Nea's explanation.
"These cells are then subjected to certain growth factors to induce cell division. There they are divided into groups. One group for one required cell type. These groups are then stimulated to differentiate into less potent stem cells. After that, the new stem cells are then transported to their final destination by the nanobots. The original cell in that place will then be destroyed by a method called cytotoxicity. The nanobots use perforin and granzymes to kill the original cell in this process. It is similar to how immune cells kill infected cells. After the original cell has died, the stem cell will be placed and stimulated to differentiate into the correct cell type. While the nanobots provide nutrients to aid the process, the new and old cells still use some nutrients from the body. This is also why you feel tired shortly after the process because the nanobots no longer provide extra nutrients."
I looked at my hand, which had undergone this process not too long ago. "Unbelievable that all this happened inside my hand," I muttered.
"The process differs slightly to replace the outer skin layers, but the base principle is the same. The nanobots are too small to store energy on their own, so they need external power. Which is provided by the induction coils you saw. After the whole process is completed, the nanobots will remain dormant and get filtered out by your kidneys."
"And how did the device prevent the pain?" I asked, actually curious.
"Nanobots, of course," Nea said with a smile. "Some nanobots search and attach themself to the nerves and block the signals responsible for pain. They will detach automatically after the energy source is removed and will get filtered out with the others."
"Alright, I think I understand it. This also explains why it could not repair Pyras foot. Without already existing tissue, there is nothing to replace."
"Correct, the device can rebuild small to medium amounts of tissue, like a missing nail or fingertip, but not a whole missing limb," Nea explained.
"Okay, now we have to find a way to include the gene editing and apply it to the whole body. The identity scanners can check the whole body, so we need to change the DNA on nearly all cells. Maybe not the brain and some critical organs, but we should stay close to or over 90%." I said, taking notes on the desk.
"That will be the most complex part. Some cells get replaced relatively often, like epithelial cells lining the gastrointestinal tract, white blood cells, and skin cells. We should be safe if we skip these cells in our process and just wait one month. But most other cells need to be replaced by the nanobots."
"Alright, noted. Could you now explain the gene editing process to me? At least what we know." I said.
"We actually know nearly everything about it." Nea stated, "The notes of the research team are highly detailed, and with cross-references to known methods, I was able to reconstruct the whole process from creating the proteins to applying them. I might not be able to refine or accelerate the process, but combining it with the process of the MedHands should be possible." Nea said while she replaced the graphs on display.
She continued, "The base method used in the process is similar to a technique developed nearly a thousand years ago. The original protein was called CRISPR-Cas9. Since then, multiple advances have been made, but most of them are still based, at least partly, on the original. Since gene editing was banned, most research subsided. While the research itself is not illegal, only the human use, most companies searched for more secluded places to continue. Because Hermes was outside the grasp of the authorities, some of them settled down here."
I lifted an eyebrow, "Thank you for the history lesson, but please get back on track." I said to Nea.
"Of course, sorry about that. Well, the process is quite simple, actually. We decide what parts of your DNA we want to change, simulate the changes and then add the changes as a blueprint to one or multiple proteins. The proteins then get injected into the cell and will search for and replace the DNA parts with the new ones. The research done at Hermes has gotten the success rate from 80% to 98% and the off-target effect down to less than 1%."